Laboratoire de Biochimie Appliquée, Faculté des Sciences de la Nature et de la Vie, Université de Bejaia, Bejaia, Algeria.
Dipartimento di Scienze e Tecnologie Ambientali, Biologiche e Farmaceutiche, Università della Campania "Luigi Vanvitelli", Caserta, Italy.
PLoS One. 2020 Apr 16;15(4):e0230690. doi: 10.1371/journal.pone.0230690. eCollection 2020.
In recent years, chronic degenerative diseases such as certain types of cancers, are becoming an evident issue. DNA damage has been for long recognized as a causal factor for cancer development because mutations or chromosomal aberrations affect oncogenes and tumor suppressor genes leading cells to malignant transformation and to the subsequent cancerous growth. Medicinal plants are often used for the prevention or treatment of various diseases with great scientific interest. Among the medicinal plants distributed in the Mediterranean region, Fraxinus angustifolia Vahl. has been used in traditional medicine for its remarkable curative properties. However, in spite of this popularity, little works have been performed on the activity so that further studies should be performed to investigate in depth the antimutagenic, antigenotoxic and antiproliferative activities of the plant. Thus, the present study was aimed to the evaluation of the potential antimutagenic, antigenotoxic and antiproliferative properties of leaves and stem bark extracts of this well-known tree. Antimutagenic activity was evaluated by Salmonella mutagenicity assay in Salmonella typhimurium TA98 and TA100 strains. The antigenotoxic potential was assessed by umu test in the strain of S. typhimurium TA1535/pSK1002. Antiproliferative activity was studied on human hepatoblastoma (HepG-2) and on breast adenocarcinoma (MCF-7) cell lines by MTT assay. Furthermore, the antiproliferative activity observed on cancer cells was compared with that on the human normal-like fibroblasts (TelCOFS02MA) and the selectivity index was calculated to understand if extracts were able to exert selective toxicity towards cancer cells. Moreover, phenolic compounds are plant substances with a large spectrum of biochemical activities with antioxidant, antimutagenic and anticarcinogenic effects. Based on the strong evidence of biological activities of phenolic compounds, the study was focused on the determination of total phenolics and flavonoids contents, and the phytochemical composition of the extracts assessed by LC/MS. The ethanol extracts of both leaves and stem barks showed significant from moderate to strong antimutagenic and antigenotoxic effects. In addition, selective cytotoxicity towards cancer cells was shown by ethanolic leaves extract and aqueous/chloroform leaves and stem bark extracts. The latter showed high levels of total phenolic contents among all the other extracts. Identified phenylethanoids (calceolariosides, verbascoside) and secoiridoids (oleuropein and ligstroside) could be responsible for the demonstrated broad spectrum of healthy properties.
近年来,某些类型的癌症等慢性退行性疾病成为一个明显的问题。人们长期以来一直认为 DNA 损伤是癌症发展的一个因果因素,因为突变或染色体异常会影响癌基因和肿瘤抑制基因,导致细胞恶性转化和随后的癌变。药用植物常被用于预防或治疗各种疾病,具有很大的科学兴趣。在分布在地中海地区的药用植物中,狭叶欧洲白蜡 (Fraxinus angustifolia Vahl.) 因其显著的治疗特性而在传统医学中被广泛应用。然而,尽管如此,对其活性的研究却很少,因此需要进一步研究以深入研究植物的抗诱变、抗原毒性和抗增殖活性。因此,本研究旨在评估这种广为人知的树木的叶子和茎皮提取物的潜在抗诱变、抗原毒性和抗增殖特性。通过在鼠伤寒沙门氏菌 TA98 和 TA100 菌株中进行沙门氏菌致突变性试验评估抗诱变活性。通过在鼠伤寒沙门氏菌 TA1535/pSK1002 菌株中的 umu 试验评估抗原毒性潜力。通过 MTT 试验在人肝癌 (HepG-2) 和乳腺癌 (MCF-7) 细胞系上研究抗增殖活性。此外,将在癌细胞上观察到的抗增殖活性与在人正常样成纤维细胞 (TelCOFS02MA) 上的活性进行比较,并计算选择性指数以了解提取物是否能够对癌细胞产生选择性毒性。此外,酚类化合物是具有抗氧化、抗诱变和抗癌作用的多种生化活性的植物物质。基于酚类化合物具有很强的生物活性证据,该研究重点在于测定总酚类和类黄酮含量,并通过 LC/MS 评估提取物的植物化学成分。叶和茎皮的乙醇提取物均表现出从中等到强的抗诱变和抗原毒性作用。此外,叶的乙醇提取物和叶和茎皮的水/氯仿提取物表现出对癌细胞的选择性细胞毒性。后者在所有其他提取物中表现出较高的总酚含量。鉴定的苯乙醇类 (calceolariosides、verbascoside) 和裂环烯醚萜类 (橄榄苦苷和 Ligstroside) 可能是证明其广泛健康特性的原因。